B29K2035/00

RESIN SHEET HAVING HAIR-LIKE BODIES AND MOLDED ARTICLE THEREOF
20230041295 · 2023-02-09 · ·

A resin sheet having: a surface layer having hair-like bodies arranged regularly on one surface thereof; and a second layer directly laminated to a surface opposite that of the hair-like bodies of the surface layer, the surface layer comprising a thermoplastic polyurethane resin and the second layer comprising a polymer alloy resin of a polycarbonate-based resin and a polyester-based and resin.

Three-Dimensional Printing Processes Using 1,1-Di-Activated Vinyl Compounds

A process for producing an article by three-dimensional printing includes applying a 1,1-di-activated vinyl compound-containing liquid binder over a predetermined area of a layer of solid particles. The liquid binder infiltrates gaps between the solid particles to form a first cross-sectional layer of an article, and the 1,1-di-activated vinyl compound reacts to solidify the liquid binder and bind the solid particles in the first cross-sectional layer of the article. Also provided is an article produced by the three-dimensional printing process, set forth herein.

UV CURABLE FORMULATIONS CONTAINING DIPROPYLENE GLYCOL DIACRYLATE
20230212327 · 2023-07-06 ·

Described herein are photopolymerizable compositions for use in 3D printing. The compositions contain dipropylene glycol diacrylate and one or more urethane acrylate oligomers, optionally with a photoinitiator. Also described are methods for fabricating three dimensional objects utilizing these compositions, and three dimensional objects made from these compositions.

Three-dimensional printing processes using 1,1-di-activated vinyl compounds

A process for producing an article by three-dimensional printing includes applying a 1,1-di-activated vinyl compound-containing liquid binder over a predetermined area of a layer of solid particles. The liquid binder infiltrates gaps between the solid particles to form a first cross-sectional layer of an article, and the 1,1-di-activated vinyl compound reacts to solidify the liquid binder and bind the solid particles in the first cross-sectional layer of the article. Also provided is an article produced by the three-dimensional printing process, set forth herein.

3D printing with polymeric nanogel particles

A photoinitiated polymerizable composition for 3D printing, the polymerizable composition comprising a nanogel component that comprises nanogel particles, wherein the nanogel particles comprise a copolymer with polymerizable reactive groups suitable for reacting with each other or a reactive diluent monomer, a reactive oligomer, a resin, or a combination thereof that is present in the polymerizable composition upon photoinitiation, wherein the nanogel component has a glass transition temperature that is in a range of about −50 C and about 20 C and an average molecular weight that is in a range of about 10 kg/mol and about 100 kg/mol, and wherein the nanoparticles have an average hydrodynamic radius that is in a range of 1 nm to about 5 nm.

ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3

The present invention relates to the treatment or prevention of skeletal disorders, in particular skeletal diseases, developed by patients that display abnormal increased activation of the fibroblast growth factor receptor 3 (FGFR3), in particular by expression of a constitutively activated mutant of FGFR3.

THERMOSET POLYMER POWDER

The invention relates to a thermoset polymer powder having a particle size D90 of 60 μm or less, determined by laser diffraction, wherein the polymer is obtainable by polymerization of compounds having one or more ethylenically unsaturated polymerizable groups, and wherein the compounds having one or more ethylenically unsaturated polymerizable groups include at least one compound having at least two ethylenically unsaturated polymerizable groups.

ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3

The present invention relates to the treatment or prevention of skeletal disorders, at particular skeletal diseases, developed by patients that display abnormal increased activation of the fibroblast growth factor receptor 3 (FGFR3), in particular by expression of a constitutively activated mutant of FGFR3.

BALLISTIC PLATE MATERIALS AND METHOD
20170234657 · 2017-08-17 ·

Embodiments of the invention provide body armor composite and methods of fabrication. The body armor composite can include at least one strike-face layer, at least one strike-face reinforcement layer, and at least one catchment layer. Some embodiments include body armor composite with a bump guard layer, and a back-face reduction layer. In some embodiments, the fabrication method includes bonding multiple layers to form an armor composite. Some embodiments include an armor production tool including a housing at least two housing portions which form a substantially air-tight chamber when closed. The tool can include a lower flexible membrane forming at least a portion of a mold, and an upper flexible membrane capable of engaging the lower flexible membrane. The tool can include a pressure port for pressurizing the chamber and to move portions of the mold towards each other, and a locking mechanism for locking the two housing portions.

Optical film, surface light emitting body, and method for producing optical film
09765941 · 2017-09-19 · ·

An optical film has a plurality of aligned convex microlenses, each of which has a region α and a region β, region β forming the outer part of the convex shape of the microlens and positioned so as to cover region α. Both region α and region β contain a resin, and the refractive index of the resin in region α is higher than the refractive index of the resin in region β; region β contains fine particles, and region α contains fine particles, and the content of the fine particles contained in region α is lower than the content of the fine particles contained in region β; or region α contains fine particles, and region β contains fine particles, and the content of the fine particles contained in region α is higher than the content of the fine particles contained in region β.